drug

Individual Placement and Support

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by University of California Riverside at C.I. Trials, Inc.-Inland Empire
4 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

4
Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia
NCT03974620—Unknown
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode
NCT02823041—Completed
Effect Evaluation of Individual Placement and Support (IPS)
NCT01964092—Completed
Improving Work Outcome in People With Recent-onset Schizophrenia
NCT00203788Phase 4Completed

KOLs & investigators

3
Keith H Nuechterlein, Ph.D.KOL score 5
Silje E Reme, PhD
Keith H. Nuechterlein, PhD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of California Riverside at C.I. Trials, Inc.-Inland Empire
company
trial
Individual Placement and Support and/or Cognitive Remediation Therapy Added to TAU in Patients With Early Schizophrenia
NA
trial
Enhancing Cognitive Training Through Exercise Following a First Schizophrenia Episode
NA
trial
Effect Evaluation of Individual Placement and Support (IPS)
NA
trial
Improving Work Outcome in People With Recent-onset Schizophrenia
PHASE4
trial
indication
Schizophrenia
indication
Substance-Related Disorders
indication
Psychological Well-Being
indication
Depression
indication
KOL
Keith H Nuechterlein, Ph.D.
KOL score 5
person
Silje E Reme, PhD
KOL score —
person
Keith H. Nuechterlein, PhD
KOL score —
person